Recruiting
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
NCT06422403
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +28 more
- Locations
-
- Department of Hematology-Oncology, National University Hospita Singapore